PHARMA NORD ApS — Credit Rating and Financial Key Figures

CVR number: 67303016
Tinglykke 4-6, Skrydstrup 6500 Vojens
tel: 74541155

Income statement (mDKK)

2019
2020
2021
2022
2023
Fiscal period length1212121212
Net sales332.99417.18470.18439.44447.39
Change in finished goods inventory9.98
Manufacturing for enterprise's own use-2.81-3.22-3.49-3.59-1.90
Other operating income0.271.482.541.56
Purchases during the financial year-80.33-84.17-97.14-79.24- 105.56
External services- 139.32- 138.62- 155.52- 178.80- 197.70
Gross profit126.14197.88222.48187.53147.58
Employee benefit expenses-92.39- 139.11- 153.51- 138.01- 119.24
Other operating expenses-0.00-0.03
Total depreciation-8.69-9.14-9.86-10.88-10.73
EBIT25.0549.6259.0838.6517.61
Other financial income2.671.831.750.921.41
Other financial expenses-2.04-3.95-1.55-5.02-8.39
Reduction non-current investment assets-0.22
Income from other inv. held as non-curr. assets0.010.010.010.01
Net income from associates (fin.)21.4914.9111.988.5215.38
Pre-tax profit47.1762.4171.0543.0826.02
Income taxes-5.67-10.46-13.08-7.79-2.69
Net earnings41.5051.9557.9735.2923.34

Assets (mDKK)

2019
2020
2021
2022
2023
Development expenditure1.811.491.081.091.46
Intangible assets total1.811.491.081.091.46
Land and waters114.36116.34118.44120.53122.41
Buildings9.4910.4711.3210.9712.75
Machinery and equipment4.404.3318.7117.8516.42
Tangible assets total128.25131.15148.47149.35151.58
Holdings in group member companies44.9347.5845.1536.0447.90
Investments total44.9347.5845.1536.0447.90
Non-current loans receivable0.010.000.010.010.01
Long term receivables total0.010.000.010.010.01
Semifinished products12.1018.257.9521.0729.69
Raw materials and consumables35.0938.3937.6251.3546.74
Finished products/goods25.9621.8726.2338.8728.41
Inventories total73.1578.5171.80111.29104.84
Current trade debtors60.1275.5374.9968.2857.01
Current amounts owed by group member comp.50.0554.1474.8364.2850.44
Prepayments and accrued income1.211.180.430.680.58
Current other receivables3.502.862.422.272.55
Short term receivables total114.88133.72152.67135.51110.57
Other current investments15.7416.6217.66
Cash and bank deposits13.785.9623.7413.7110.73
Cash and cash equivalents29.5222.5841.3913.7110.73
Balance sheet total (assets)392.56415.02460.57447.01427.09

Equity and liabilities (mDKK)

2019
2020
2021
2022
2023
Share capital0.200.200.200.200.20
Shares repurchased100.0030.0050.0045.00
Other reserves0.520.463.870.853.44
Retained earnings127.5187.8287.31101.69133.59
Profit of the financial year41.5051.9557.9735.2923.34
Shareholders equity total269.73170.43199.35183.03160.56
Provisions12.2113.5714.0117.2317.70
Non-current loans from credit institutions39.0335.5053.7351.0748.41
Non-current other liabilities1.304.78
Non-current liabilities total40.3340.2753.7351.0748.41
Current loans from credit institutions8.2552.9880.7390.85151.42
Current trade creditors40.3422.3319.5918.7822.34
Current owed to participating0.480.440.440.380.53
Current owed to group member4.0054.573.6745.185.24
Short-term deferred tax liabilities3.919.1012.544.282.12
Other non-interest bearing current liabilities13.3151.3376.5036.2118.77
Current liabilities total70.29190.75193.48195.69200.42
Balance sheet total (liabilities)392.56415.02460.57447.01427.09
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.